- Home
- OBIO vs DOYU Comparison
OBIO vs DOYU Comparison
Compare OBIO & DOYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- DOYU
- Stock Information
- Founded
- OBIO 2017
- DOYU 2014
- Country
- OBIO United States
- DOYU China
- Employees
- OBIO N/A
- DOYU N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- DOYU Computer Software: Programming Data Processing
- Sector
- OBIO Health Care
- DOYU Technology
- Exchange
- OBIO Nasdaq
- DOYU Nasdaq
- Market Cap
- OBIO 147.8M
- DOYU 246.3M
- IPO Year
- OBIO N/A
- DOYU 2019
- Fundamental
- Price
- OBIO $2.51
- DOYU $7.72
- Analyst Decision
- OBIO Strong Buy
- DOYU Hold
- Analyst Count
- OBIO 4
- DOYU 1
- Target Price
- OBIO $14.00
- DOYU $7.00
- AVG Volume (30 Days)
- OBIO 240.7K
- DOYU 77.5K
- Earning Date
- OBIO 11-11-2025
- DOYU 08-18-2025
- Dividend Yield
- OBIO N/A
- DOYU 255.21%
- EPS Growth
- OBIO N/A
- DOYU N/A
- EPS
- OBIO N/A
- DOYU N/A
- Revenue
- OBIO $2,944,000.00
- DOYU $586,290,301.00
- Revenue This Year
- OBIO $29.26
- DOYU N/A
- Revenue Next Year
- OBIO $10.65
- DOYU N/A
- P/E Ratio
- OBIO N/A
- DOYU N/A
- Revenue Growth
- OBIO 41.61
- DOYU N/A
- 52 Week Low
- OBIO $2.37
- DOYU $5.68
- 52 Week High
- OBIO $6.50
- DOYU $16.99
- Technical
- Relative Strength Index (RSI)
- OBIO 41.34
- DOYU 47.06
- Support Level
- OBIO $2.45
- DOYU $7.55
- Resistance Level
- OBIO $2.68
- DOYU $7.83
- Average True Range (ATR)
- OBIO 0.11
- DOYU 0.35
- MACD
- OBIO -0.02
- DOYU -0.03
- Stochastic Oscillator
- OBIO 17.65
- DOYU 32.10
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.